Journal of Neural Transmission

, Volume 112, Issue 10, pp 1297–1308 | Cite as

Modulation of phospholipase A2 activity in primary cultures of rat cortical neurons

  • C. T. Mendes
  • W. F. Gattaz
  • E. L. Schaeffer
  • O. V. Forlenza


In neurons, phospholipase A2 (PLA2) plays a central role in the regulation of membrane phospholipid metabolism. We have addressed the pharmacological modulation of PLA2 in primary cultures of rat cortical neurons. Inhibition curves were obtained in 4 day-in-culture neurons treated for 30 minutes with either the dual PLA2 inhibitor methyl arachidonyl fluorophosphonate (MAFP), or the iPLA2 inhibitor bromoenol lactone (BEL). Full inhibition was achieved with 100 and 250 µM of MAFP, or 10 and 20 µM of BEL. Conversely, a dose-dependent activation of PLA2 was obtained with 10–20 µg/ml of melitin. PLA2 inhibition with MAFP or BEL was not acutely toxic for cultured neurons. However, sustained inhibition of the enzyme precluded the development of neurites, and resulted in long-term loss of neuronal viability. We present a model of pharmacological challenge of PLA2 in vitro, which can be further used to address the involvement of the enzyme in neurodevelopment and neurodegeneration models.

Keywords: Phospholipids, phospholipase A2, PLA2, neurons, primary culture, radio-enzymatic assay. 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Ackermann, EJ, Conde-Frieboes, K, Dennis, EA 1995Inhibition of macrophage Ca(2+)-independent phospholipase A2 by bromoenol lactone and trifluoromethyl ketones.J Biol Chem270445450CrossRefPubMedGoogle Scholar
  2. Balsinde, J, Dennis, EA 1997Function and inhibition of intracellular calcium-independent phospholipase A2.J Biol Chem2721606916072CrossRefPubMedGoogle Scholar
  3. Balsinde, J, Winstead, MV, Dennis, EA 2002Phospholipase A2 regulation of arachidonic acid mobilization.FEBS Lett53126CrossRefPubMedGoogle Scholar
  4. Blusztajn, JK, Liscovitch, M, Richardson, UI 1987Synthesis of acetylcholine from choline derived from phosphatidylcholine in a human neuronal cell line.Proc Natl Acad Sci USA8454745477PubMedGoogle Scholar
  5. Chen, J, Engle, SJ, Seilhamer, JJ, Tischfield, JÁ 1994Cloning and recombinant expression of a novel human low molecular weight Ca(2+)-dependent phospholipase A2.J Biol Chem26923652368PubMedGoogle Scholar
  6. Clark, JD, Lin, L-L, Kriz, RW, Ramesha, CS, Sultzman, LA, Lin, AY, Milona, N, Knopf, JL 1991A novel arachidonic acid-selective cytosolic PLA2 contains a Ca2+-dependent translocation domain with homology to PKC and GAP.Cell6510431051CrossRefPubMedGoogle Scholar
  7. Cupillard, L, Koumanov, K, Mattei, MG, Lazdunski, M, Lambeau, G 1997Cloning, chromosomal mapping, and expression of a novel human secretory phospholipase A2.J Biol Chem2721574515752CrossRefPubMedGoogle Scholar
  8. Emmerling, MR, Moore, CJ, Doyle, PD, Carroll, RT, Davis, RE 1993Phospholipase A2 activation influences the processing and secretion of the amyloid precursor protein.Biochem Biophys Res Commun197292297CrossRefPubMedGoogle Scholar
  9. Farooqui, AA, Litsky, ML, Farooqui, T, Horrocks, LA 1999Inhibitors of intracellular phospholipase A2 activity: their neurochemical effects and therapeutical importance for neurological disorders.Brain Res Bull49139153CrossRefPubMedGoogle Scholar
  10. Flesch, I, Schmidt, B, Ferber, E 1985Acyl-chain specificity and kinetic properties of phospholipase A1 and A2 of bone E marrow-derived macrophages.Z Naturforsch [C]40356363Google Scholar
  11. Fletcher, JE, Tripolitis, L, Rosenberg, H, Beech, J 1993Malignant hyperthermia: halothane- and calcium-induced calcium release in skeletal muscle.Biochem Mol Biol Int29763772PubMedGoogle Scholar
  12. Forlenza, OV, Schaeffer, EL, Gattaz, WF 2002Phospholipase A2 activity in rat embryonic brain and in primary cultures of cortical neurons.J Neural Transm109623631CrossRefPubMedGoogle Scholar
  13. Gattaz, WF, Köllisch, M, Thuren, T, Virtanen, JA, Kinnunen, PKJ 1987Increased plasma phospholipase-A2 activity in schizophrenic patients: reduction after neuroleptic therapy.Biol Psychiatry22421426CrossRefPubMedGoogle Scholar
  14. Gattaz, WF, Maras, A, Cairns, NJ, Levy, R, Förstl, H 1995aDecreased phospholipase A2 activity in Alzheimer brains.Biol Psychiatry371317CrossRefGoogle Scholar
  15. Gattaz, WF, Steudle, A, Maras, A 1995bIncreased platelet phospholipase A2 in schizophrenia.Schizophr Res1616CrossRefGoogle Scholar
  16. Gattaz, WF, Cairns, NJ, Levy, R, Forstl, H, Braus, DF, Maras, A 1996Decreased phospholipase A2 activity in the brain and in platelets of patients with Alzheimer’s disease.Eur Arch Psychiatry Clin Neurosci246129131CrossRefPubMedGoogle Scholar
  17. Gattaz, WF, Forlenza, OV, Talib, LL, Barbosa, NR, Bottino, CM 2004Platelet phospholipase A(2) activity in Alzheimer’s disease and mild cognitive impairment.J Neural Transm111591601CrossRefPubMedGoogle Scholar
  18. Hattori, K, Adachi, H, Matsuzawa, A, Yamamoto, K, Tsujimoto, M, Aoki, J, Hattori, M, Arai, H, Inoue, K 1996Cloning and expression of intracellular platelet-activating factor (paf) acetylhydrolase II.J Biol Chem2713303233038CrossRefPubMedGoogle Scholar
  19. Hwang, TC, Guggino, SE, Guggino, WB 1990Direct modulation of secretory chloride channels by arachidonic and other cis unsaturated fatty acids.Proc Natl Acad Sci USA8757065709PubMedGoogle Scholar
  20. Ikemoto, A, Kobayashi, T, Watanabe, S, Okuyama, H 1997Membrane fatty acid modifications of PC12 cells by arachidonate or docosahexaenoate affect neurite outgrowth but not norepinephrine release.Neurochem Res22671678CrossRefPubMedGoogle Scholar
  21. Kadoyama, K, Takahashi, Y, Higashida, H, Tanabe, T, Yoshimoto, T 2001Cyclooxygenase-2 stimulates production of amyloid beta-peptide in neuroblastoma × glioma hybrid NG108-15 cells.Biochem Biophys Res Commun281483490CrossRefPubMedGoogle Scholar
  22. Kim, D, Clapham, DE 1989Potassium channels in cardiac cells activated by arachidonic acid and phospholipids.Science24411741176PubMedGoogle Scholar
  23. MacDonell, LE, Skinner, FK, Ward, PE, Glen, AI, Glen, AC, Macdonald, DJ, Boyle, RM, Horrobin, DF 2000Increased levels of cytosolic phospholipase A2 in dyslexics.Prostagland Leukot Essent Fatty Acids633739CrossRefGoogle Scholar
  24. Miller, B, Sarantis, M, Traynelis, SF, Attwell, D 1992Potentiation of NMDA receptor currents by arachidonic acid.Nature355722725PubMedGoogle Scholar
  25. Mosmann, T 1983Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.J Immunol Methods655563PubMedGoogle Scholar
  26. Nevalainen, TJ, Haapanen, TJ 1993Distribution of pancreatic (group I) and synovial-type (group II) phospholipases A2 in human tissues.Inflammation17453464CrossRefPubMedGoogle Scholar
  27. Noponen, M, Sanfilipo, M, Samanich, K, Ryer, H, Ko, G, Angrist, B, Wolkin, A, Rotrosen, J 1993Elevated PLA2 activity in schizophrenics and other psychiatric patients.Biol Psychiatry34641649CrossRefPubMedGoogle Scholar
  28. Ross, BM, Hudson, C, Erlich, J, Wars, JJ, Kish, SJ 1997Increased phospholipid breakdown in schizophrenia.Arch Gen Psychiatry54487494PubMedGoogle Scholar
  29. Schaeffer EL, Gattaz WF (2004) Inhibition of Ca2+-independent phospholipase A2 in rat hippocampus impairs short- and long-term memory formation. Psychopharmacology (submitted)Google Scholar
  30. Simonato, M 1993A pathogenetic hypothesis of temporal lobe epilepsy.Pharmacol Res27217225CrossRefPubMedGoogle Scholar
  31. Shier, WT 1979Activation of high levels of endogenous phospholipase A2 in cultured cells.Proc Natl Acad Sci USA76195199PubMedGoogle Scholar
  32. Smalheiser, NR, Dissanayake, S, Kapil, A 1996Rapid regulation of neurite outgrowth and retraction by phospholipase A2-derived arachidonic acid and its metabolites.Brain Res7213948CrossRefPubMedGoogle Scholar
  33. Stephenson, DT, Manetta, JV, White, DL, Chiou, XG, Cox, L, Gitter, B, May, PC, Sharp, JD, Kramer, RM, Clemens, JA 1994Calcium-sensitive cytosolic phospholipase A2 (cPLA2) is expressed in human brain astrocytes.Brain Res63797105CrossRefPubMedGoogle Scholar
  34. Tang, J, Kriz, RW, Wolfman, N, Shaffer, M, Seehra, J, Jones, SS 1997A novel cytosolic calcium-independent phospholipase A2 contains eight ankyrin motifs.J Biol Chem27285678575CrossRefPubMedGoogle Scholar
  35. Underwood, KW, Song, C, Kriz, RE, Chang, XJ, Knopf, JL, Lin, LL 1998A novel calcium-independent phospholipase A2, cPLA2γ, that is prenylated and contains homology to cPLA2.J Biol Chem2732192621932CrossRefPubMedGoogle Scholar
  36. Visioli, F, Rodriguez-de-Turco, EB, Kreisman, NR, Bazan, NG 1994Membrane lipid degradation is related to interictal cortical activity in a series of seizures.Metab Brain Dis9161170CrossRefPubMedGoogle Scholar
  37. Williams, EJ, Walsh, FS, Doherty, P 1994The production of arachidonic acid can account for calcium channel activation in the second messenger pathway underlying neurite outgrowth stimulated by NCAM, N-cadherin, and L1.J Neurochem6212311234PubMedGoogle Scholar
  38. Woelk, H, Peiler-Ichikawa, K 1974Zur Aktivität der Phospholipase A2 gegenüber verschiedenen 1-Alk-1′-enyl-2-acyl- und 1-Alkyl-2-acyl-Verbindungen während der multiplen Sklerose.J Neurol207319326CrossRefPubMedGoogle Scholar
  39. Yao, JK, Leonard, S, Reddy, RD 2000Membrane phospholipid abnormalities in postmortem brains from schizophrenic patients.Schizophr Res42717CrossRefPubMedGoogle Scholar
  40. Yoshihara, Y, Yamaji, M, Kawasaki, M, Watanabe, Y 1992Ontogeny of cytosolic phospholipase A2 activity in rat brain.Biochem Biophys Res Commun185350355CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag/Wien 2005

Authors and Affiliations

  • C. T. Mendes
    • 1
  • W. F. Gattaz
    • 1
  • E. L. Schaeffer
    • 1
  • O. V. Forlenza
    • 1
  1. 1.Laboratory of Neuroscience (LIM-27), Department and Institute of Psychiatry, Faculty of MedicineUniversity of São PauloBrazil

Personalised recommendations